Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting
NCT02411396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 483
Last updated 2019-06-27
Summary
The Emergency Department has been the standard location where patients with Sickle Cell Disease (SCD) go to seek care for the treatment of acute painful events. Vaso- Occlusive Crisis (VOC) is the most common complication of SCD,
The purpose of this study is to compare patient centered outcomes for patients being treated for an uncomplicated VOC in Infusion Centers (IC) and Emergency Departments (ED) in four locations around the United States.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Sophie Lanzkron, MD, MHS · Johns Hopkins University, Division of Hematology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- United States
Study Locations
More Related Trials
-
High-flow Oxygen for Vaso-occlusive Pain Crisis
NCT03976180 ·Status: RECRUITING ·Phase: NA
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Megakaryocyte Heterogeneity in Sickle Cell Disease
NCT06850337 ·Status: NOT_YET_RECRUITING
-
Prognostic Factors of Acute Splenic Sequestration
NCT01207037 ·Status: COMPLETED ·Phase: NA
-
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
NCT03380351 ·Status: COMPLETED
-
Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events
NCT02539771 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA
-
Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease
NCT01501643 ·Status: TERMINATED ·Phase: NA
-
Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
NCT01419977 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients
NCT03226691 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
NCT06023199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NCT07246265 ·Status: RECRUITING ·Phase: NA
-
A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises
NCT02698761 ·Status: TERMINATED ·Phase: NA
-
Ketamine Sickle Cell Disease
NCT03502421 ·Status: WITHDRAWN ·Phase: PHASE3
-
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
NCT03805581 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)
NCT05289700 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease
NCT00560261 ·Status: COMPLETED ·Phase: PHASE3
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING
-
Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.
NCT06823219 ·Status: RECRUITING ·Phase: NA
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease
NCT06214845 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
NCT05376046 ·Status: RECRUITING